Ascelia Pharma AB is an oncology-focused drug development company based in Malmö, Sweden, specializing in orphan drugs. Founded in 2000, the company is committed to addressing unmet medical needs through the development and commercialization of innovative therapies. Its lead product, Mangoral, is a novel non-gadolinium contrast agent currently in Phase III clinical trials for MRI scans of the liver. Additionally, Ascelia is advancing Oncoral, an oral chemotherapy tablet in Phase II trials aimed at treating gastric cancer. Through these initiatives, Ascelia Pharma seeks to provide effective treatment options for patients with specific oncology needs.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Natural Cycles is a pioneering company in the field of digital contraception, focusing on female reproductive health through its contraceptive app. The app enables users to track their basal body temperature each morning, which, along with other data such as luteinizing hormone levels, is processed by an algorithm to determine fertility status. By analyzing individual inputs, the app forecasts which days women are fertile, providing a color-coded calendar to indicate when unprotected intercourse may be feasible. Users are required to measure and enter their body temperature daily using a basal thermometer for accurate predictions. This subscription-based service aims to simplify fertility tracking and empower women in managing their reproductive health.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Fast Travel Games AB is a game development studio based in Stockholm, Sweden, founded in 2016 by veterans from renowned companies such as EA DICE, Rovio, and Avalanche. The studio specializes in creating virtual reality games that emphasize rich narratives and social interaction. Fast Travel Games aims to transform the gaming experience by allowing players to explore immersive environments and engage with each other in innovative ways. The company's focus is on developing games that encourage teamwork and provide deep, engrossing universes for players to enjoy with friends, all supported by VR technology.
OxThera AB is a biopharmaceutical company based in Stockholm, Sweden, with an additional location in Knoxville, Tennessee. Founded in 2005, it focuses on developing treatments for primary and secondary hyperoxaluria, a condition that can lead to kidney stones and impaired kidney function. The company's leading products include Oxabact, an oral formulation of live bacteria designed to enhance the elimination of oxalate produced in the body, and Oxazyme, a recombinant enzyme aimed at managing dietary oxalate and preventing kidney stone formation. Oxabact has received Orphan Drug designations in both Europe and the United States, underscoring its potential in treating primary hyperoxaluria. OxThera holds global patents for its innovative approaches using bacteria and enzymes to address hyperoxaluria, contributing to advancements in kidney disease management.
Neo4j, Inc. specializes in developing a graph database platform that enables organizations to understand and leverage the relationships within their data. This platform facilitates the connection of various deployments and customer applications, addressing complex data challenges across industries such as financial services, retail, government, and telecommunications. Neo4j's technology supports a range of applications, including artificial intelligence, analytics, fraud detection, identity management, knowledge graphs, and recommendation engines. By adopting a relationships-first approach, the platform helps clients to unlock business value and adapt to changing needs while managing data at scale. Founded in 2007 and headquartered in San Mateo, California, Neo4j also maintains offices in Sweden, the United Kingdom, and France, reinforcing its position as a leader in graph database technology.
Freespee AB is a technology company specializing in call monetization solutions for the performance advertising sector, primarily operating in Europe and North America. Founded in 2008 and headquartered in Uppsala, Sweden, with additional offices in Helsinki, Copenhagen, and Berlin, Freespee provides various products aimed at enhancing communication and marketing efforts. Its offerings include Freespee Performance, which allows publishers and advertising networks to monetize phone calls generated from their media properties, and Freespee Analytics, a comprehensive tool for tracking leads and analyzing call data. Additionally, the Freespee Mobile Tracking SDK assists app developers in understanding consumer engagement through phone calls. By integrating multiple data sources, Freespee aims to facilitate personalized interactions between brands and their customers, thereby improving the overall consumer experience.
Werlabs AB is a medical technology company based in Stockholm, Sweden, founded in 2013 by Will Stoddart and general practitioner Rickard Lagerqvist. The company specializes in direct-to-consumer blood analysis and health checkup services, enabling individuals to monitor and improve their health. Werlabs offers comprehensive health analysis through blood testing, which is reviewed by medical professionals. Customers gain access to a private online journal, providing them with the tools and information necessary to understand their health status and minimize the risk of common diseases. Through its services, Werlabs aims to empower users to take charge of their health.
Fast Travel Games AB is a game development studio based in Stockholm, Sweden, founded in 2016 by veterans from renowned companies such as EA DICE, Rovio, and Avalanche. The studio specializes in creating virtual reality games that emphasize rich narratives and social interaction. Fast Travel Games aims to transform the gaming experience by allowing players to explore immersive environments and engage with each other in innovative ways. The company's focus is on developing games that encourage teamwork and provide deep, engrossing universes for players to enjoy with friends, all supported by VR technology.
Natural Cycles is a pioneering company in the field of digital contraception, focusing on female reproductive health through its contraceptive app. The app enables users to track their basal body temperature each morning, which, along with other data such as luteinizing hormone levels, is processed by an algorithm to determine fertility status. By analyzing individual inputs, the app forecasts which days women are fertile, providing a color-coded calendar to indicate when unprotected intercourse may be feasible. Users are required to measure and enter their body temperature daily using a basal thermometer for accurate predictions. This subscription-based service aims to simplify fertility tracking and empower women in managing their reproductive health.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Boozt Fashion AB is an e-commerce company based in Malmö, Sweden, founded in 2007. It specializes in selling a wide range of clothing, shoes, and accessories for women, men, and children. The company's product offerings include apparel, sportswear, bags, innerwear, and various accessories. Boozt operates webshops for multiple prominent Nordic fashion brands, covering the Northern European market. In addition to its own platform, it provides e-commerce solutions that integrate online and offline channels for Scandinavian apparel companies. With a workforce of approximately 45 employees in Sweden and an offshore team in Vietnam and India, Boozt continues to expand its brand partnerships and enhance its online retail capabilities.
Natural Cycles is a pioneering company in the field of digital contraception, focusing on female reproductive health through its contraceptive app. The app enables users to track their basal body temperature each morning, which, along with other data such as luteinizing hormone levels, is processed by an algorithm to determine fertility status. By analyzing individual inputs, the app forecasts which days women are fertile, providing a color-coded calendar to indicate when unprotected intercourse may be feasible. Users are required to measure and enter their body temperature daily using a basal thermometer for accurate predictions. This subscription-based service aims to simplify fertility tracking and empower women in managing their reproductive health.
Neo4j, Inc. specializes in developing a graph database platform that enables organizations to understand and leverage the relationships within their data. This platform facilitates the connection of various deployments and customer applications, addressing complex data challenges across industries such as financial services, retail, government, and telecommunications. Neo4j's technology supports a range of applications, including artificial intelligence, analytics, fraud detection, identity management, knowledge graphs, and recommendation engines. By adopting a relationships-first approach, the platform helps clients to unlock business value and adapt to changing needs while managing data at scale. Founded in 2007 and headquartered in San Mateo, California, Neo4j also maintains offices in Sweden, the United Kingdom, and France, reinforcing its position as a leader in graph database technology.
Pulmologix AB is a Swedish private clinical stage company focused on developing, manufacturing, and selling an oral non-steroidal anti-asthmatic drug designed for the treatment of early onset allergic asthma. Established in 2006 and headquartered in Stockholm, the company aims to address unmet medical needs in asthma management through its innovative therapeutic approach.
Tink AB, founded in 2012 and headquartered in Stockholm, Sweden, operates as a cloud-based open banking platform that enhances financial services through its infrastructure and data products. The company offers a mobile application that allows users to track personal finances, manage money across various accounts, transfer funds, pay bills, and establish personal budgets. Key features of the application include transaction categorization, spending insights, and daily analyses. Additionally, Tink provides products such as account aggregation, payment initiation, and data enrichment, which can be utilized for standalone services or integrated into existing banking applications. The company's partnerships with major financial institutions, including ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB, further bolster its position in the financial technology sector.
Cantargia AB is a biotechnology company based in Lund, Sweden, focused on developing antibody-based therapies for serious diseases, particularly cancer and autoimmune conditions. The company specializes in targeting the Interleukin-1 Receptor Accessory Protein (IL1RAP), which is expressed in certain leukemic stem cells and various cancers. Its lead product candidate, CAN04, is designed to recognize and bind to cancer cells, enhancing the immune system's ability to eliminate these cells while also reducing tumor-related inflammation. Cantargia is also working on additional antibody candidates, including CAN10, to address a broader range of diseases. Founded in 2010, the company has established collaborations to further its research and development efforts.
Neo4j, Inc. specializes in developing a graph database platform that enables organizations to understand and leverage the relationships within their data. This platform facilitates the connection of various deployments and customer applications, addressing complex data challenges across industries such as financial services, retail, government, and telecommunications. Neo4j's technology supports a range of applications, including artificial intelligence, analytics, fraud detection, identity management, knowledge graphs, and recommendation engines. By adopting a relationships-first approach, the platform helps clients to unlock business value and adapt to changing needs while managing data at scale. Founded in 2007 and headquartered in San Mateo, California, Neo4j also maintains offices in Sweden, the United Kingdom, and France, reinforcing its position as a leader in graph database technology.
Freespee AB is a technology company specializing in call monetization solutions for the performance advertising sector, primarily operating in Europe and North America. Founded in 2008 and headquartered in Uppsala, Sweden, with additional offices in Helsinki, Copenhagen, and Berlin, Freespee provides various products aimed at enhancing communication and marketing efforts. Its offerings include Freespee Performance, which allows publishers and advertising networks to monetize phone calls generated from their media properties, and Freespee Analytics, a comprehensive tool for tracking leads and analyzing call data. Additionally, the Freespee Mobile Tracking SDK assists app developers in understanding consumer engagement through phone calls. By integrating multiple data sources, Freespee aims to facilitate personalized interactions between brands and their customers, thereby improving the overall consumer experience.
Neo4j, Inc. specializes in developing a graph database platform that enables organizations to understand and leverage the relationships within their data. This platform facilitates the connection of various deployments and customer applications, addressing complex data challenges across industries such as financial services, retail, government, and telecommunications. Neo4j's technology supports a range of applications, including artificial intelligence, analytics, fraud detection, identity management, knowledge graphs, and recommendation engines. By adopting a relationships-first approach, the platform helps clients to unlock business value and adapt to changing needs while managing data at scale. Founded in 2007 and headquartered in San Mateo, California, Neo4j also maintains offices in Sweden, the United Kingdom, and France, reinforcing its position as a leader in graph database technology.
Acarix A/S is a medical device company based in Kongens Lyngby, Denmark, specializing in the non-invasive detection of coronary artery disease (CAD). Founded in 2009, Acarix developed the CADScor System, which utilizes advanced acoustics and artificial intelligence to provide a rapid diagnosis for patients experiencing chest pain. The system is designed to accurately rule out CAD in under ten minutes, significantly reducing the need for unnecessary invasive procedures and associated costs. Acarix operates in several markets, including Germany, Sweden, and Denmark, and has received both CE marking and DeNovo approval from the FDA for its CADScor System. The company's foundation is rooted in research from Aalborg University, and it has garnered support from various investors and public funding initiatives to advance its innovative solutions in the field of cardiovascular diagnostics.
Neo4j, Inc. specializes in developing a graph database platform that enables organizations to understand and leverage the relationships within their data. This platform facilitates the connection of various deployments and customer applications, addressing complex data challenges across industries such as financial services, retail, government, and telecommunications. Neo4j's technology supports a range of applications, including artificial intelligence, analytics, fraud detection, identity management, knowledge graphs, and recommendation engines. By adopting a relationships-first approach, the platform helps clients to unlock business value and adapt to changing needs while managing data at scale. Founded in 2007 and headquartered in San Mateo, California, Neo4j also maintains offices in Sweden, the United Kingdom, and France, reinforcing its position as a leader in graph database technology.